CEACAM5 and neoplasm: All other factors analyzed including age, sex, race, site of primary tumor, ECOG performance status, Child-Pugh Score, MELD score, EGFR Inhibitor Treatment (in the pre- or post-Y90 timeframe), pre-Y90 CEA, tumor size (cm), and tumor volume (cc) did not predict OS in WT compared to MUT groups.